7,531.25

-43.00

-0.57%

52,433.00

-65.00

-0.12%

27,741.00

-273.50

-0.98%

Russell 2000 Futures

2,822.90

-25.80

-0.91%

4.9580

+0.0940

+1.93%

21.00

+1.08

+5.42%

4,060.30

-54.20

-1.32%

73,638.99

-1,148.51

-1.54%

Crude Oil Dec 26

84.45

-2.40

-2.76%

US Private Equity

10,850.15

0.00

0.00%

NasdaqCM - Nasdaq Real Time Price USD

XTL Biopharmaceuticals Ltd. (XTLB)

1.5301 -0.0199 (-1.28%)

At close: November 9 at 4:00:00 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

XTL Completed the Acquisition of Psyga Bio Ltd.

GlobeNewswire 4mo ago

XTLB
0.00%
XTL Announces Receipt of Staff Delist Determination from Nasdaq

GlobeNewswire 5mo ago

^IXIC

XTLB
0.00%
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

GlobeNewswire 6mo ago

XTLB
0.00%
XTL Biopharmaceuticals Announces ADS Ratio Change

GlobeNewswire 7mo ago
XTL Update on Recent Developments

GlobeNewswire 9mo ago

XTLB
0.00%
XAIR
Top Midday Gainers

PREMIUM
MT Newswires 9mo ago

XAIR

BCTX

XTLB
0.00%
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire 9mo ago

XTLB
0.00%
XAIR
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership

GlobeNewswire 9mo ago

XAIR

XTLB
0.00%
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

GlobeNewswire 10mo ago

XTLB
0.00%
^IXIC

Performance Overview

Return	XTLB	TA-125 (^TA125.TA)
YTD	-45.35%	+8.47%
1-Year	-61.75%	+15.81%
3-Year	-55.00%	--

Mobilize your Website

View Site in Mobile | Classic

Share by: